Q2 2024 Afya Ltd Earnings Call Transcript
Key Points
- Net revenue increased by almost 14%, reaching BRL810 million.
- Adjusted EBITDA grew by 28% year-over-year, reaching BRL344 million with a margin of 42.5%.
- Adjusted net income saw a 59% growth, reaching BRL210 million.
- Robust cash flow from operating activities totaled BRL610 million, a 21% year-over-year increase.
- Medical seats increased to 3,583 approved seats, with a 9% growth in the number of medical students.
- B2B revenue in continuing education saw a 13% decrease.
- The competitive environment for prep courses remains challenging, with significant sales only expected in the fourth quarter.
- Integration of new acquisitions like Unidom is still in progress, with synergies yet to be fully realized.
- The restructuring of digital and continuing education segments is ongoing, which may cause short-term disruptions.
- Net debt remains high at BRL1,459 million, despite a reduction from the previous year.
Thank you for joining us for Afya's Conference Call. I'm here today with Afya's CEO, Virgilio Gibbon, and our CFO, Luis Andre Blanco. During today's presentation, our executives will make forward-looking statements. Forward-looking statements can be related to future events, future financial or operating performance, known and unknown risks, uncertainties, and other factors that may cause Afya's actual results to differ materially from those contemplated by these forward-looking statements.
Forward-looking statements in this presentation include, but are not limited to, statements related to the business and financial performance, expectations and guidance for future periods, or expectations regarding the company's strategic product initiatives and its related benefits. These risks include those more fully described in our filings with the Securities and Exchange Commission.
The forward-looking statements in this presentation are based on the information available to us as the date hereof. We should not rely on them as predictions of future events,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
